Oesophageal atresia
Type de document :
Article dans une revue scientifique: Article de synthèse/Review paper
PMID :
URL permanente :
Titre :
Oesophageal atresia
Auteur(s) :
Van Lennep, Marinde [Auteur]
Singendonk, Maartje M. J. [Auteur]
Dall''oglio, Luigi [Auteur]
Gottrand, fréderic [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Krishnan, Usha [Auteur]
Terheggen-Lagro, Suzanne W. J. [Auteur]
Omari, Taher I. [Auteur]
Benninga, Marc A. [Auteur]
Van Wijk, Michiel P. [Auteur]
Singendonk, Maartje M. J. [Auteur]
Dall''oglio, Luigi [Auteur]
Gottrand, fréderic [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Krishnan, Usha [Auteur]
Terheggen-Lagro, Suzanne W. J. [Auteur]
Omari, Taher I. [Auteur]
Benninga, Marc A. [Auteur]
Van Wijk, Michiel P. [Auteur]
Titre de la revue :
Nature reviews Disease primers
Nom court de la revue :
Nat Rev Dis Primers
Numéro :
5
Pagination :
26
Date de publication :
2019-04-18
ISSN :
2056-676X
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Oesophageal atresia (EA) is a congenital abnormality of the oesophagus that is caused by incomplete embryonic compartmentalization of the foregut. EA commonly occurs with a tracheo-oesophageal fistula (TEF). Associated ...
Lire la suite >Oesophageal atresia (EA) is a congenital abnormality of the oesophagus that is caused by incomplete embryonic compartmentalization of the foregut. EA commonly occurs with a tracheo-oesophageal fistula (TEF). Associated birth defects or anomalies, such as VACTERL association, trisomy 18 or 21 and CHARGE syndrome, occur in the majority of patients born with EA. Although several studies have revealed signalling pathways and genes potentially involved in the development of EA, our understanding of the pathophysiology of EA lags behind the improvements in surgical and clinical care of patients born with this anomaly. EA is treated surgically to restore the oesophageal interruption and, if present, ligate and divide the TEF. Survival is now ~90% in those born with EA with severe associated anomalies and even higher in those born with EA alone. Despite these achievements, long-term gastrointestinal and respiratory complications and comorbidities in patients born with EA are common and lead to decreased quality of life. Oesophageal motility disorders are probably ubiquitous in patients after undergoing EA repair and often underlie these complications and comorbidities. The implementation of several new diagnostic and screening tools in clinical care, including high-resolution impedance manometry, pH-multichannel intraluminal impedance testing and disease-specific quality of life questionnaires now provide better insight into these problems and may contribute to better long-term outcomes in the future.Lire moins >
Lire la suite >Oesophageal atresia (EA) is a congenital abnormality of the oesophagus that is caused by incomplete embryonic compartmentalization of the foregut. EA commonly occurs with a tracheo-oesophageal fistula (TEF). Associated birth defects or anomalies, such as VACTERL association, trisomy 18 or 21 and CHARGE syndrome, occur in the majority of patients born with EA. Although several studies have revealed signalling pathways and genes potentially involved in the development of EA, our understanding of the pathophysiology of EA lags behind the improvements in surgical and clinical care of patients born with this anomaly. EA is treated surgically to restore the oesophageal interruption and, if present, ligate and divide the TEF. Survival is now ~90% in those born with EA with severe associated anomalies and even higher in those born with EA alone. Despite these achievements, long-term gastrointestinal and respiratory complications and comorbidities in patients born with EA are common and lead to decreased quality of life. Oesophageal motility disorders are probably ubiquitous in patients after undergoing EA repair and often underlie these complications and comorbidities. The implementation of several new diagnostic and screening tools in clinical care, including high-resolution impedance manometry, pH-multichannel intraluminal impedance testing and disease-specific quality of life questionnaires now provide better insight into these problems and may contribute to better long-term outcomes in the future.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Date de dépôt :
2024-01-30T10:26:36Z
2024-02-06T09:42:31Z
2024-02-06T09:42:31Z